The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit

被引：24
|
作者：
Messori, Andrea [1 ]
Trippoli, Sabrina [1 ]
机构：
[1] ESTAR, HTA Unit, Reg Hlth Serv, Via San Salvi 12, I-50135 Florence, Italy
来源：
HEART | 2017年 / 103卷 / 21期
关键词：
D O I：
10.1136/heartjnl-2017-311816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1746 / 1746
页数：1
相关论文
共 50 条
  • [31] A study on confidence intervals for incremental cost-effectiveness ratios
    Wang, Hongkun
    Zhao, Hongwei
    [J]. BIOMETRICAL JOURNAL, 2008, 50 (04) : 505 - 514
  • [32] RISK-BENEFIT ASSESSMENT USING THE LIKELIHOOD HELPED OR HARMED RATIO: SIMILARITIES AND DIFFERENCES WITH INCREMENTAL COST-EFFECTIVENESS RATIOS
    O'Day, K.
    Meyer, K. L.
    [J]. VALUE IN HEALTH, 2019, 22 : S291 - S291
  • [33] Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
    Anthony O’Hagan
    John W. Stevens
    Jacques Montmartin
    [J]. PharmacoEconomics, 2000, 17 : 339 - 349
  • [34] Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio
    O'Hagan, A
    Stevens, JW
    Montmartin, J
    [J]. PHARMACOECONOMICS, 2000, 17 (04) : 339 - 349
  • [35] Complementing the net benefit approach: A new framework for Bayesian cost-effectiveness analysis
    Negrin Hernandez, Miguel Angel
    Jose Vazquez-Polo, Francisco
    Giron Gonzalez-Torre, Francisco Javier
    Moreno Bas, Elias
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (04) : 537 - 545
  • [36] From the Therapeutic Utility to the Added Therapeutic Value and the Incremental Cost-Effectiveness Ratio
    Puig-Junoy, Jaume
    Peiro, Salvador
    [J]. REVISTA ESPANOLA DE SALUD PUBLICA, 2009, 83 (01): : 59 - 70
  • [37] THE INCREMENTAL COST-EFFECTIVENESS RATIO (ICER) THRESHOLDS IN CENTRAL AND EASTERN EUROPEAN COUNTRIES
    Augustynska, J.
    Skora, K.
    Leszczynska, A.
    Seweryn, M.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S159 - S159
  • [38] Net benefit separation and the determination curve: A probabilistic framework for cost-effectiveness estimation
    Spieker, Andrew J.
    Illenberger, Nicholas
    Roy, Jason A.
    Mitra, Nandita
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (05) : 1306 - 1319
  • [39] The Impact of Outliers on Net-Benefit Regression Model in Cost-Effectiveness Analysis
    Wen, Yu-Wen
    Tsai, Yi-Wen
    Wu, David Bin-Chia
    Chen, Pei-Fen
    [J]. PLOS ONE, 2013, 8 (06):
  • [40] A Bayesian Net Benefit Approach to Cost-effectiveness Analysis in Health Technology Assessment
    Moreno, Elias
    Javier Giron, Francisco
    Jose Vazquez-Polo, Francisco
    Negrin, Miguel A.
    [J]. INTERNATIONAL JOURNAL OF THE ECONOMICS OF BUSINESS, 2009, 16 (03) : 323 - 345
12345